These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Fecal transplantation indications in ulcerative colitis. Preliminary study. Laszlo M; Ciobanu L; Andreica V; Pascu O Clujul Med; 2016; 89(2):224-8. PubMed ID: 27152073 [TBL] [Abstract][Full Text] [Related]
46. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. Buttó LF; Haller D Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757 [TBL] [Abstract][Full Text] [Related]
47. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection. Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Nair Parvathy S; Chen Y; Silverman MS; Routy JP Front Med (Lausanne); 2020; 7():421. PubMed ID: 32850913 [TBL] [Abstract][Full Text] [Related]
48. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981 [TBL] [Abstract][Full Text] [Related]
49. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients. Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD mBio; 2018 Mar; 9(2):. PubMed ID: 29535202 [TBL] [Abstract][Full Text] [Related]
50. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists. Syal G; Kashani A; Shih DQ Am J Med; 2018 Sep; 131(9):1017-1024. PubMed ID: 29605414 [TBL] [Abstract][Full Text] [Related]
51. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? Bringiotti R; Ierardi E; Lovero R; Losurdo G; Di Leo A; Principi M World J Gastrointest Pathophysiol; 2014 Nov; 5(4):550-9. PubMed ID: 25400998 [TBL] [Abstract][Full Text] [Related]
52. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938 [TBL] [Abstract][Full Text] [Related]
54. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. Zhou Y; Xu ZZ; He Y; Yang Y; Liu L; Lin Q; Nie Y; Li M; Zhi F; Liu S; Amir A; González A; Tripathi A; Chen M; Wu GD; Knight R; Zhou H; Chen Y mSystems; 2018; 3(1):. PubMed ID: 29404425 [TBL] [Abstract][Full Text] [Related]
55. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum. Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679 [TBL] [Abstract][Full Text] [Related]
56. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? Satokari R Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554 [TBL] [Abstract][Full Text] [Related]
57. Definition and evaluation of mucosal healing in clinical practice. Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331 [TBL] [Abstract][Full Text] [Related]
58. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041 [TBL] [Abstract][Full Text] [Related]